| "CHANGE COVID-19 Severity" |
| A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans |
| A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection |
| A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes as a Single Dose Regimen to SARS-CoV-2 Uninfected Ad |
| A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic |
| A Faithful Response to COVID-19 Project |
| A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. |
| A Longitudinal Study of COVID-19 Sequelae and Immunity |
| A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures |
| A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab |
| A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine |
| A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Youn |
| A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19. |
| A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 |
| A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19 |
| A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure |
| A Retrospective Study of COVID-19 Treatments |
| A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals |
| A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old |
| A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19 |
| A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19 |
| A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infec |
| A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) |
| A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER-PEDS) |
| A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection |
| A Study of LAM-002A for the Prevention of Progression of COVID-19 |
| A Study of Quintuple Therapy to Treat COVID-19 Infection |
| A Study of Risk Factors for the COVID-19 Virus Infection |
| A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine |
| A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind |
| A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) |
| A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients |
| A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age |
| A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Parti |
| A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects |
| A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 |
| A Study to Explore the Role of Gut Flora in COVID-19 Infection |
| A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 Infection |
| A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults |
| A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness |
| A Trial of NT-I7 in COVID-19 (SPESELPIS) |
| A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Imm |
| A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects |
| A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19 Infection |
| Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE |
| Acceptability/Feasibility of COVID-19 Intervention |
| ACCESS A Master Digital Surveillance Protocol for COVID-19 |
| ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 |
| ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19 |
| ACTIV-6: COVID-19 Study of Repurposed Medications |
| Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic |
| AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation |
| Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19 |
| Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol |
| An Experiment to Evaluate the Safety of agenT-797 in Participants With Severe Difficulty Breathing Secondary to SARS-CoV-2 (COVID-19) or Influenza |
| An Observational Study of Neurologic Function After COVID-19 Infection |
| An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization |
| An Outpatient Study Investigating Non-prescription Treatments for COVID-19 |
| Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma |
| Analysis of the Immune Response to COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations |
| Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors |
| ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings |
| Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial) |
| Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) |
| ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers |
| ASCO Survey on COVID-19 in Oncology (ASCO) Registry |
| Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin |
| Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction |
| Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis |
| Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic |
| Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program |
| Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce |
| AT1001 for the Treatment of COVID-19 Related MIS-C |
| At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study |
| Atorvastatin as Adjunctive Therapy in COVID-19 |
| Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps |
| AV-001 for Hospitalized Patients With COVID-19 Disease |
| Balance Function in Patients Post-COVID-19 |
| Baseline Vitamin D Deficiency and COVID-19 Disease Severity |
| Beat COVID-19 - Observational Trial |
| Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Setting |
| Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 |
| BIO 300 Oral Suspension in Discharged COVID-19 Patients |
| Blood Volume Assessment in COVID-19 ICU Patients - BVAC19 |
| Brain Health in the Time of COVID-19 |
| Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study |
| Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 |
| Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors |
| Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) |
| Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors |
| Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons |
| Cardiopulmonary Rehabilitation in COVID-19 Longhaulers |
| Cardiovascular Manifestations of COVID-19 |
| Cardiovascular Manifestations of COVID-19 |
| Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate |
| Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19) |
| CATCH-UP Vaccines: Extension of Community - Engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations (COVID-19) |
| CBD Oil for Reducing Emotional Impact of COVID-19 |
| Cellular Senescence and COVID-19 Long-Hauler Syndrome |
| Cereset Research In Healthcare Workers During COVID-19 |
| Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations |
| Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs |
| Clazakizumab vs. Placebo - COVID-19 Infection |
| Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel |
| Clinical Performance Evaluation of SARS-CoV-2 (COVID-19) Antigen Assay in Point of Care Settings |
| Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test |
| Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID) |
| Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama |
| Cognitive Training in Survivors of Covid-19: A Randomized Trial |
| Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development |
| Communities Fighting COVID-19! |
| Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US |
| Comparison of ME/CFS and Long COVID-19 Patients |
| Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) |
| Compass Course: COVID-19 |
| CONFIDENT: Supporting Long-term Care Workers During COVID-19 |
| Contrast Enhanced Ultrasound in COVID-19 |
| Convalescent Plasma as a Possible Treatment for COVID-19 |
| Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection |
| Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection |
| Conversations You Want About Corona Virus Disease (COVID-19) |
| Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome |
| Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation |
| Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use |
| Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients |
| Cough Sound Recordings to Understand COVID-19-like Symptom Progression to Understand COVID-19-like Symptom Progression |
| COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes |
| COVID-19 Active Research Experience (CARE) |
| COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric P |
| COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry |
| COVID-19 and Cancer Consortium Registry |
| COVID-19 and Obstetric Transmission |
| Covid-19 Associated Coagulopathy |
| COVID-19 Associated Lymphopenia Pathogenesis Study in Blood |
| COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI) |
| COVID-19 Biorepository |
| COVID-19 Booster Vaccination in Persons With Multiple Sclerosis |
| COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders |
| COVID-19 Close Contact Self-Testing Study |
| COVID-19 Coagulopathy Extension Study |
| COVID-19 Community Research Partnership |
| COVID-19 Convalescent Plasma (CCP) Transfusion |
| COVID-19 Diagnostic Self-testing Using Virtual Point-of-care |
| COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients |
| COVID-19 International Drug Pregnancy Registry |
| COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry |
| COVID-19 Messaging for Vaccination |
| COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol |
| COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol |
| COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study |
| CoVID-19 Plasma in Treatment of COVID-19 Patients |
| COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes |
| COVID-19 Project ECHO in Nursing Homes |
| COVID-19 Public Image Registry |
| COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV |
| COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications |
| COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation |
| COVID-19 Respiratory Outcomes Registry |
| COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS) |
| COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy |
| COVID-19 Risk Reduction Among African American Parishioners |
| COVID-19 Screening Program |
| COVID-19 Self-Testing Through Rapid Network Distribution |
| COVID-19 Serologic Strategies for Skilled Nursing Facilities |
| COVID-19 Survivorship Registry |
| COVID-19 Symptom Tracker |
| COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis |
| COVID-19 Vaccine Biomarker Study in Multiple Sclerosis |
| COVID-19 Vaccine Response in Chronic Respiratory Conditions |
| COVID-19 Vaccine Response in Sickle Cell Disease |
| COVID-19 Vaccine Responses in PIDD Subjects |
| COVID-19 Vaccines International Pregnancy Exposure Registry |
| COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial) |
| COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies |
| Covid-19 Virtual Recovery Study |
| COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE) |
| COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) |
| COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II |
| COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients |
| COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents |
| CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia. |
| Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment |
| Cromolyn Sodium for Treatment of COVID-19 Pneumonia |
| Crowdsourcing an Open COVID-19 Imaging Repository for AI Research |
| Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake |
| Cyclosporine For The Treatment Of COVID-19(+) |
| Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19 |
| Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial |
| Defibrotide for the Treatment of Severe COVID-19 |
| Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 |
| Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT |
| Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19 |
| Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence |
| Developing and Testing a COVID-19 Vaccination Acceptance Intervention |
| Does Framing and Humor Improve the Effectiveness of Messages About COVID-19 Vaccine |
| Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 |
| Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects |
| Dual MRI for Cardiopulmonary COVID-19 Long Haulers |
| Duke COVID-19 Shared Data and Specimen Repository |
| Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19 |
| Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness |
| Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE) |
| Efficacy and Safety of COVID-19 Vaccine in Cancer Patients |
| Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication |
| Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction |
| Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19 |
| Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2) |
| Electrical Stimulation for Critically Ill Post-Covid-19 Patients |
| Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic |
| Endocrine, Metabolic and Microbiome Influence on the Post COVID-19 Syndrome |
| EPIC-Peds: Study of Oral PF-07321332 (Nirmatrelvir)/Ritonavir in Nonhospitalized COVID-19 Pediatric Patients at Risk for Severe Disease |
| Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota |
| EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ) |
| Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients |
| Estradiol and Progesterone in Hospitalized COVID-19 Patients |
| Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound |
| Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 |
| Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults |
| Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients |
| Evaluating Public Health Interventions to Improve COVID-19 Testing Among Underserved Populations |
| Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic |
| Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents and Young Adults With Cancer |
| Evaluation of Point-of-Care (EPOC) for COVID-19 |
| Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). |
| Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation |
| Exercise and COVID-19 Viral T-cell Immunity |
| Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19 |
| Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth |
| Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients |
| Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers |
| Fluoxetine to Reduce Intubation and Death After COVID19 Infection |
| FREEDOM COVID-19 Anticoagulation Strategy |
| General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19 |
| Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function |
| Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination |
| GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) |
| GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19) |
| Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19 |
| Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes |
| Health Factors and Immune Response to Coronavirus Disease 2019 (COVID-19) Vaccine |
| Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts) |
| Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19 |
| HEALthy Brain and Child Development Study - COVID-19 Supplement |
| High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 |
| Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study |
| Homeopathic Treatment of Post-acute COVID-19 Syndrome |
| Host Immune Response to Novel RNA COVID-19 Vaccination |
| Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) |
| Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) |
| Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 |
| Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia |
| Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela |
| Hyperpolarized 129Xe MRI of Survivors of COVID-19 |
| IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing. |
| Imaging Immune Activation in COVID-19 |
| Immune Response Following COVID-19 Vaccination |
| Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
| Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis |
| Immune Responses to COVID-19 Infection or Vaccination |
| ImmuneSense COVID-19 Variant Study |
| Immunity After COVID-19 Vaccination |
| Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults |
| Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies |
| Immunological Responses of COVID-19 Vaccination |
| Impact of COVID-19 on GU Disease |
| Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery |
| Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients |
| Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate |
| Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic |
| Impact of the Coronavirus (COVID-19) on Patients With Cancer |
| Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors |
| Implementation of COVID-19 Testing Strategies in Community Health Centers |
| Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic |
| Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island |
| Improving Cognitive Health in COVID-19 Survivors |
| Improving COVID-19 Vaccine Uptake Among Black and Latino Youth |
| Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks |
| Improving Thinking in Everyday Life After Covid-19 |
| Incidence and Predictors of Acute and Chronic Complications in Patients With Diabetes and Severe COVID-19 |
| Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation |
| Increasing COVID-19 Testing in Chicago's African American Testing Desserts |
| Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) |
| Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 |
| Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE) |
| Intravenous Zotatifin in Adults With Mild or Moderate COVID-19 |
| Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients |
| Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19) |
| Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection |
| IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation. |
| Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis |
| I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients |
| Kidney Disease After COVID-19 |
| KIDney Injury in Times of COVID-19 (KIDCOV) |
| Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy |
| Leflunomide in Mild COVID-19 Patients |
| Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) |
| Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO |
| Leveraging Social Networks to Increase COVID-19 Testing Uptake |
| LinkUP: COVID-19 Intervention for Underserved Populations |
| Long Term Outcomes of Patients With COVID-19 |
| Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) |
| Long-term Effects of COVID-19 |
| Long-term Impact of Infection With Novel Coronavirus (COVID-19) |
| Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise |
| Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19 |
| Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia |
| Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 |
| Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery |
| Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy |
| LYT-100 in Post-acute COVID-19 Respiratory Disease |
| Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation |
| Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) |
| Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients |
| Mellowing Mind: Comparing Two Technology Based Mindfulness Interventions for Stress Impacted by COVID-19 in Underserved Communities |
| Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias |
| Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) |
| Methodist Health System COVID-19 Patient Registry |
| MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey |
| Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19 |
| Mind Body Intervention for COVID-19 Long Haul Syndrome |
| Mindfulness Practice in Pregnancy as an Intervention to Decrease Prenatal Stress During the COVID-19 Pandemic |
| Mobile Health and COVID-19 |
| Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study |
| Mother-infant Bonding During COVID-19 |
| MP1032 Treatment in Patients With Moderate to Severe COVID-19 |
| MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients |
| mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels |
| MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study |
| Multilevel Community-Based Mental Health Intervention to Address Structural Inequities and Adverse Disparate Consequences of COVID-19 Pandemic on Lati |
| Multimodal Investigation of Post COVID-19 in Females |
| MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) |
| Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination |
| N95 Reuse During COVID-19 |
| NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection |
| Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases |
| Natural History Study of COVID-19 Using Digital Wearables |
| NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients |
| Nebulised Heparin in Patients With Severe COVID-19 |
| Nebulized Heparin for COVID19-associated Acute Respiratory Failure |
| Neurologic Manifestations of COVID 19 in Children |
| Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 |
| Non-contact ECG Sensor System for COVID19 |
| Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection |
| Novel Experimental COVID-19 Therapies Affecting Host Response |
| Observational Maternal COVID-19 Vaccination Study |
| Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19 |
| Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients |
| Oscillation and Lung Expansion Therapy in Patients With COVID-19 |
| Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19 |
| Parental Perception of COVID-19 Vaccine in Technology Dependent Patients |
| Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic |
| Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment |
| Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic |
| Patient Reported Health-Related Quality of Life Associated With COVID-19. |
| Pediatrics HOT COVID-19 Database in NY Tristate |
| Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test |
| Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 |
| Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California |
| Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study |
| Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19 |
| Phase 1 Study of Intranasal PIV5-vectored COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults |
| Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure |
| Phase 2a MIB-626 vs. Placebo COVID-19 |
| Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study |
| Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients |
| Physical Rehabilitation of COVID-19 Survivors by Heat Therapy |
| Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients |
| Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19 |
| Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome |
| Pilot Test of COVID-19 Related Clinical Outcome Assessment Methodology and Qualitative Evidence of Content Validity |
| Pilot Trial of XFBD, a TCM, in Persons With COVID-19 |
| Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 |
| Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine |
| POC Study to Evaluate the Performance of the AcuVid COVID-19 Rapid Antigen Saliva Test |
| Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19 |
| Post Acute Sequelae of COVID-19 |
| Post COVID-19 Biorepository |
| Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study |
| Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States |
| PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice |
| Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic |
| Prevention of COVID-19 Infection to Severe Pneumonia or ARDS |
| Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 |
| Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California |
| Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol |
| Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19 |
| Prophylaxis and Treatment of COVID-19 |
| Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients |
| Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 |
| PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS |
| Protecting Native Families From COVID-19 |
| Pulmozyme to Improve COVID-19 ARDS Outcomes |
| QuadraMune(TM) for Prevention of COVID-19 |
| Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year |
| Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection |
| Ramipril for the Treatment of COVID-19 |
| Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome |
| Rapid Turnaround, Home-based Saliva Testing for COVID-19 |
| Ravulizumab and COVID-19 |
| Real World Study of COVID-19 in a Flyover Region |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 |
| Recovery of Respiratory System in COVID-19 Patients |
| Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations |
| Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER) |
| Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use |
| REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19) |
| Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test |
| REsearching Covid-19 Outcomes in Diabetes (RECODE) |
| Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era |
| Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients |
| Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic |
| Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children |
| Risk Stratification of COVID-19 Using Urine Biomarkers |
| Risks of Bacterial and Fungal Superinfection in Patients With COVID-19 |
| Role of Children in Transmission of COVID-19 to Immunocompromised Patients |
| Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis |
| Safety and Effectiveness of EV-Pure + WJ-Pure Treatment on Pulmonary Fibrosis Secondary to Covid-19 |
| Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome |
| Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 |
| Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19 |
| Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 |
| Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen |
| Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients |
| Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults |
| Safety of Pediatric COVID-19 Vaccination |
| Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19 |
| Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia |
| Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19 |
| Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. |
| SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial |
| SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease |
| SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer |
| SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers |
| SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers |
| Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence |
| Serologic Response to the SARS-CoV-2 (COVID-19) mRNA-1273 Vaccine in Select Subsets of Oncology Patients |
| Serological Surveillance for COVID-19 in Central North Carolina |
| Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza) |
| Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) |
| Simultaneous mRNA COVID-19 and IIV4 Vaccination Study |
| Single-Blind Study of STAT-205 in Mild COVID-19 |
| Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia |
| Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections |
| SP16 as a Therapeutic for COVID-19 Induced ARDS |
| St. Jude Tracking of Viral and Host Factors Associated With COVID-19 |
| Stay Connected: Testing an Intervention to Combat COVID-19 Related Social Isolation Among Seattle-area Older Adults |
| Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) |
| Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol) |
| Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress |
| Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 |
| Study of LAU-7b for the Treatment of COVID-19 Disease in Adults |
| Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013) |
| Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19 |
| Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients |
| Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older |
| Study of Varespladib in Patients Hospitalized With Severe COVID-19 |
| Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients |
| Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection |
| Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients. |
| Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Re |
| Study Utilizing BIOZEK COVID-19 Antigen Rapid Test |
| Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic |
| Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays |
| T CELL THERAPY OPPOSING NOVEL COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS |
| TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood |
| Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD) |
| The Burden of COVID-19 Survivorship |
| The C3I COVID-19 Project |
| The COVID-19 Back-to-Normal Study |
| The Effect of Aromatherapy on COVID-19-induced Anxiety |
| The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors |
| The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19 |
| The Evaluation of Hemostasis in Hospitalized COVID-19 Patients |
| The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin |
| The Impact of COVID-19 on Maternal and Neonatal Outcomes |
| The Impact of COVID-19 on Pulmonary Procedures |
| The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change |
| The Lymphoma and Leukemia Society Amended COVID-19 Registry |
| The Nanowear Wearable Covid-19 Observational and Analysis Trend |
| The Role of Resistant Starch in COVID-19 Infection |
| The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection |
| The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19) |
| The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose |
| The SINCERE Intervention to Address COVID-19 Health Disparities |
| The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 |
| Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection |
| Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients |
| To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment |
| To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. |
| Tools for Wellbeing COVID-19 National Study of Undergraduate Students |
| Total-Body Parametric 18F-FDG PET of COVID-19 |
| Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection |
| Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure |
| Treat COVID-19 Patients With Regadenoson |
| Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19 |
| Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 |
| Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS) |
| Trial of Imatinib for Hospitalized Adults With COVID-19 |
| Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 |
| Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS |
| Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS |
| Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients |
| Understanding the Long-term Impact of COVID-19 in Adults |
| UPMC OPTIMISE-C19 Trial, a COVID-19 Study |
| Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis |
| Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infect |
| Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19 |
| Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress |
| Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting |
| Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection |
| VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease |
| VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans |
| Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry |
| Viral Specific T Cell Therapy for COVID-19 Related Pneumonia |
| Vitamin D for COVID-19 Trial |
| Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection |
| Vocal Feature Analysis Algorithm for COVID-19 Detection |
| Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms |
| Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic |
| Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic |
| Yale COVID-19 Recovery Study |
| Zofin to Treat COVID-19 Long Haulers |